Work

Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: a phase I and pharmacokinetic study in patients with advanced cancer

Year: 2005

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdi318

Authors: A.H.G. Hansma, H.J. Broxterman, I. van der Horst, Y. Yuana, E. Boven, G. Giaccone, H.M. Pinedo, K. Hoekman

Institution: Amsterdam UMC Location Vrije Universiteit Amsterdam

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2145381652

FWCI: 2.991

Cites: 44

Cited by: 61

Related to: 10